Relentless Health Value

Mike Dendy is Vice Chairman & CEO of Advanced Medical Pricing Solutions (AMPS), an Atlanta, GA-based health care cost management company, serving the self-funded (ERISA) payer community. Since joining the Company in 2005, Mike has overseen all aspects of AMPS management, ranging from sales and marketing, to finance and client relations. AMPS has seen organic growth of over 300% over the last 5 years and has continued to increase its offerings in the health care cost containment space. AMPS clients range in size from those in the Fortune 500 to mid-sized regional employers. Prior to joining AMPS, Mike served as Chairman & CEO of HPS Paradigm Administrators Inc. from 1997 until its subsequent sale in 2004. HPS Paradigm is a health insurance Third-Party Administrator (TPA) serving corporate and government employer groups throughout the United States. During his tenure as CEO, HPS Paradigm experienced strong corporate growth, increasing on average 50% in fee income per year, while achieving industry leading EBITDA margins of over 22%. In 2000, Mike oversaw HPS' business process outsourcing (BPO) relationship with Memorial Hospital of Savannah, Georgia, which at the time was one of Georgia's largest hospital systems. Mike served as Executive Director of Memorial's TPA, HMO, PPO, UR/UM and Case Management services provided for the benefit of Chatham County area employers. From 1992-1997, Mike founded and managed Health Partners Services, Inc. (HPS), a brokerage and consulting firm, which specialized in stop-loss insurance, benefit plan design, provider negotiations, pharmacy benefit management, disease management, predictive analysis, and cost containment. HPS developed community health system plans in a number of southeastern US markets and grew consulting revenues to $600,000 annually. Mike holds 2 master's degrees, from Georgia State University in Business Administration (MBA), and Healthcare Administration (MHA) and bachelor's degrees from the University of Georgia in both Journalism and Psychology. In addition to his graduate and undergraduate achievements, Mike attended executive management programs at Harvard's Business, Public Health, and Law Schools. Mike serves on the Advisory Board for the Robinson College of Business and the School of Healthcare Administration at Georgia State University and is the former Board Chairman for the National Safe Care Campaign. Mike was awarded the School of Health Administration's Healthcare Executive of the Year in 2015. You can learn more at www.advancedpricing.com

Lisa R. Erwin is President of The E2 Group, LLC a managed markets consulting company that specializes in Medicare Part D clinical program strategic and operational expertise with a strong focus on Quality and Star Ratings. She also serves as VP of Clinical Strategies for Aventria/Pinnacle Health Communications, a managed market agency. A common theme of Ms. Erwin's 30-year pharmacy career encompassing long-term care, managed-care and hospital pharmacy has been a focus on improving the quality of medication utilization in the senior population. Most recently, Lisa held the position of Senior Director, Medicare Clinical Quality for Catamaran, a pharmacy benefit manager based in Schaumburg, Illinois. In her role at Catamaran, Lisa directed the company STAR ratings strategy and developed analytic and clinical intervention programs with an emphasis on close health plan client collaboration. She also has served as Pharmacy Director for Medicare Business at Blue Cross Blue Shield of Michigan, a provider of PDP and MAPD offerings. As Vice President, Clinical Operations for Omnicare, Inc., the largest institutional pharmacy provider in the United States, she oversaw the implementation of clinical and health management initiatives which were which were uniquely designed to serve 1.2 million residents of skilled facilities, assisted living and other institutions in 48 states. Erwin is a graduate of the University of Michigan College of Pharmacy and has been credentialed as a Certified Geriatric Pharmacist by the Commission for Certification in Geriatric Pharmacy. She has served as a member of the ASCP Task Force on Medication Therapy Management and the Editorial Advisory Board for The Consultant Pharmacist journal. Lisa held the position of co-chair of Stakeholder Advisory Panel (SAP-B) for the Pharmacy Quality Alliance (PQA) in 2015 and currently is an appointed member of the Measure Update Panel (MUP) for PQA.

In April 2013, Dr. Hunt was appointed CPHO (Chief Population Health Officer [CMO/CMIO]) for St. Vincent's Health Partners, Inc., a Physician Hospital Organization with more than 400 providers, and St. Vincent's Medical Center. Dr. Hunt provides physician leadership and direction for the planning, design and implementation of clinical information systems at St. Vincent's Health Partners, Inc. and oversees quality and utilization for its provider network. Under the leadership of Dr. Hunt, St. Vincent's Health Partners, Inc. was the first organization in the country to become accredited and re-accredited by URAC as a Clinically Integrated Network and is leading the charge in changing the face of healthcare in CT. Currently, working with organizational leaders, Dr. Hunt is engaged to develop information system infrastructure to support a super clinically integrated network. As Chief Executive Officer (2016), he is now focused to develop additional opportunities for medical management with employers and payers, enhance network contracting, and continue to support organizational transformation to value reimbursement. Dr. Hunt joined St. Vincent's Health System (SVHS) as CMIO in August 2014. He is working closely with clinical and information technology associates to transition to ongoing operations after the Cerner EMR implementation. Additionally, Dr. Hunt participates with the Valued Care Alliance [VCA] (a newly formed six hospital consortium in Connecticut in which St. Vincent's Medical Center is a founding member) to establish system-wide population management infrastructure. The VCA has been recognized as a leading advanced network by Connecticut and participates with the Community and Clinical Integration Program, and awarded the Accountable Health Communities (AHC) model grant by CMS. Dr. Michael Hunt, EP133. Defining Attribution. How do you define Fee-for-Service Attribution? How do you align your operations to manage and maximize all sides of your business? "Depending on your business model and how you look at those attributions, you define success."

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device and pharmacy clients by creating partnerships with other health care organizations. For twenty years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 Incrementalism - Worth it? 01:51 "The CEO's Guide to Restoring the American Dream: How to Deliver World-Class Healthcare to Your Employees at Half the Cost," by Dave Chase. 02:25 What would Amazon do differently by building a System of Care? 03:15 Does our conviction about the current Healthcare System stop us from creating something better? 04:15 Divestiture Aversion - Why a Healthcare reboot isn't such a bad idea. 11:00 "What are the ramifications if Amazon enters more deeply into that hybrid online-inperson space?" 12:45 How did we get where we are now? - Check out INBW13, INBW12, INBW10. 13:00 Only three stakeholders that have an invested interest in keeping Healthcare Value high: Employers, Taxpayers, and Consumers. 13:20 Large Employers as the only stakeholder with the power to make change in Healthcare. 16:50 Who is going to be behind such a reboot? 19:00 How onsite clinics might be the future and greatly benefit reducing healthcare costs. 20:00 The divorce of patient care and industry needs. 21:50 "Employers don't just have skin in the game, they have entire bodyparts." 22:50 "Employers have a larger call; healthcare is a means to an end for them."

Mr. Steinhart has had a distinguished career as an entrepreneur, investor and executive in the healthcare industry. He has been instrumental in starting or investing in many technology-based companies, several of which have developed products that have become the standard of care in their respective markets. Currently Mr. Steinhart sits on the Board of Directors of Actinium Pharmaceuticals, Inc., a New York-based biopharmaceutical company developing innovative targeted therapies for patients with cancers lacking effective treatment options. Mr. Steinhart is also a member of the Board of Directors of Atossa Genetics, a clinical-stage Seattle-based drug- company that is developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. Earlier in his career Mr. Steinhart was the Sr. Vice President and CFO at MELA Sciences, a company that received FDA approval for and marketed the world's only non-invasive Melanoma detector. Prior to MELA Sciences, he was a General Partner and CFO at CW Group, Inc., the country's first venture capital firm focused solely on medical technology and biopharmaceutical companies. Mr. Steinhart has also had significant experience in municipal government. He introduced the first mandatory Health Saving Account (HSA) insurance coverage for municipal works in the state of Connecticut. By working with union representatives and insurance company executives, Mr. Steinhart was able to craft a program that delivered high quality affordable healthcare benefits to union workers, while at the same time saving his local municipality millions of dollars in premiums. This program has been widely emulated by many of the 169 towns and cities in Connecticut. Mr. Steinhart currently live in Ridgefield Connecticut with his wife and two sons. He can be reached by e-mail at Richard.Steinhart@comcast.net

Jennifer E. Miller, PhD, is an Assistant Professor at the NYU School of Medicine and President of the nonprofit, Bioethics International. She is also the Creator of the Good Pharma Scorecard, an index that ranks all new drugs and large pharmaceutical companies on their ethics and public health performance to help recognize good practices in companies, improve trustworthiness, and incentivize change where needed. Prior to joining NYU, Dr. Miller was based at Harvard University. Dr. Miller currently serves on NYU's Pharmacy and Therapeutics Committee and Stem Cell Research Oversight IRB, as well as the J&J-NYU Compassionate-Use Advisory Committee (monitor). Previously, she served on the Center for Disease Control and Prevention's (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association's (AMA) Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations Economic and Social Council, and on the PCORI-NIH Collaboratory. A prolific writer, Dr. Miller has authored over 35 publications, including for Nature Medicine and Health Affairs. She was a Fox News pundit from 2009 to 2012 and remains a news commentator, frequently featured on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, and NPR. Dr. Miller's current work explores the ethics and governance of new drugs that are researched, developed, marketed, priced, and made accessible to patients globally. She also specializes in the ethics of data sharing. You can learn more at www.bioethicsinternational.org and view the Good Pharma Scorecard.

Founder and CEO of Fit4D, David Weingard David is a diabetes patient who was diagnosed with Type 1 diabetes at the age of 36 while training for a survival race. A veteran of numerous running and triathlon races (including Ironman triathlons consisting of a 2.4M swim, 112M bike and 26.2M run), David committed to rebuild his life and provide positive energy to the diabetes community while coping with the condition on a 24/7 basis. Beginning with shorter races, he gradually learned how to successfully race triathlons with diabetes and within a year, completed the famous Escape from Alcatraz Triathlon in San Francisco Bay. He then began racing Ironman triathlons again – though this time, working through the delicate balance between insulin, food, nutrition and exercise. Through these races, David has fundraised extensively on behalf of the Juvenile diabetes Research Foundation's (JDRF) New York City Chapter. David's personal experience receiving meaningful education and support from a Certified Diabetes Educator (CDE) sparked the idea for Fit4D to leverage technology to scale the patient reach of adherence and outcome improvement programs for pharmaceutical, payer and provider organizations. In 2008, David left Microsoft to found Fit4D, building on his career as an executive in the technology sector. As the founder and CEO of Fit4D, David received the PM360 Elite Entrepreneur award for transforming the diabetes landscape. Under David's leadership PM360 also named Fit4D one of the top innovative healthcare startups in 2015, while ePharma named Fit4D its 2016 audience winner of the Disruptive Technology Showcase and Innovations Challenge. David is transforming the diabetes landscape and improving people's health in the real world every day. David was selected as the Keynote Speaker for the American Diabetes Association's largest fundraising event, Step Out: Walk to Stop Diabetes, 2016. David has given back to the diabetes community by coaching the JDRF Ride to Cure Diabetes and the American Diabetes Association's Tour De Cure many times, and gives back to the entrepreneur community by guiding emerging health technology founders. As a chosen finalist for the Novo Nordisk-Lyfebulb Patient Entrepreneur award, David participated in a panel on patient-centric innovation, sharing his message of hope to an international audience. Most recently, David was the recipient of the first-ever Kate Granger Compassionate Care Award, spotlighting individual contributions to high-tech/high-touch care and awarded to those who demonstrate compassionate care in this area. You can find out more at www.fit4d.com or email info@fit4d.com

Tom Kottler is co-founder and Chief Executive Officer of HealthPrize Technologies, which uses gamification, behavioral economics and consumer marketing concepts to engage and motivate patients. HealthPrize works with top and emerging life science companies to inspire patient loyalty, maximize medication adherence and improve health literacy. Kottler has led multiple high-growth organizations during his career, including Advanced BioHealing, which was acquired by Shire for $750 million, and MedAptus, an innovative healthcare IT company based in Boston, Mass. You can learn more at www.healthprize.com

Andrew Schorr is a medical journalist who was diagnosed with chronic lymphocytic leukemia (CLL) in 1996 and has remained in remission since then. He is the founder of HealthTalk.com, PatientPower.info and PatientPower.eu. He is board chair of the Patient Empowerment Foundation in Europe. He is also the author of The Web-Savvy Patient: An Insider's Guide to Navigating the Internet When Facing Medical Crisis, which was published in 2011. Andrew is a graduate of UNC-Chapel Hill and holds a master's degree in journalism from Columbia University.

Julie is an executive pharmaceutical leader with over 20 years of experience across all phases of development both on the commercial and research sides of the organization. She leverages her Masters in Business Administration and Doctorate of Pharmacy to develop and deliver strategic patient-centric value propositions to optimize patient access and improve outcomes in patients with difficult to treat diseases leading to longer, healthier, and more productive lives. Her years of experience in global and US payer markets provides Julie with intimate knowledge of the current and evolving payer and market access landscape in the US and around the globe. She has led the development and execution of several outcomes-based contracts with 3 of the largest national payer organizations in the US. Dr. Locklear is well published, having authored >30 publications in peer-reviewed journals and >60 peer-reviewed abstracts presented as posters at major scientific congresses.